A newly targeted protein could unlock a more powerful, multi-pronged way to slow Alzheimer’s. Credit: Shutterstock Alzheimer's disease is often described in numbers, with millions of people affected, cases rising quickly, and costs reaching into the trillions. For families, however, the experience is deeply personal. "It's a slow bereavement," says Cold Spring Harbor Laboratory Professor Nicholas Tonks, whose mother lived with Alzheimer's. "You lose the person piece by piece." A major focus in